DEXCOM INC

DXCM Nasdaq CIK: 0001093557

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation DE
Business Address 6340 SEQUENCE DRIVE, SAN DIEGO, CA, 92121
Mailing Address 6340 SEQUENCE DRIVE, SAN DIEGO, CA, 92121
Phone 8582000200
Fiscal Year End 1231
EIN 330857544

Financial Overview

FY2025

$6.48B
Total Assets
$2.75B
Stockholders' Equity
$917.70M
Cash & Equivalents
$2.14
EPS

Recent SEC Filings

Form Type Date Filed Document
8-K Current report of material events February 12, 2026 View on SEC
10-K Annual financial report February 12, 2026 View on SEC
4 Insider stock transaction report February 2, 2026 View on SEC
4 Insider stock transaction report February 2, 2026 View on SEC
4 Insider stock transaction report February 2, 2026 View on SEC
4 Insider stock transaction report February 2, 2026 View on SEC
4 Insider stock transaction report February 2, 2026 View on SEC
8-K Current report of material events January 12, 2026 View on SEC
8-K Current report of material events December 22, 2025 View on SEC
4 Insider stock transaction report November 17, 2025 View on SEC

Annual Reports

10-K February 12, 2026
  • Successful global launch and strong user adoption of the G7 CGM system.
  • Expanded market access, including Medicare coverage for Type 2 non-insulin users in the U.S.
View Analysis

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.